Diagnostic Imaging Devices Market Set for Steady Growth to USD 52.6 Billion by 2033, Led by North America's 40% Global Market Share | DataM Intelligence

The Global Diagnostic Imaging Devices Market reached USD 33.7 billion in 2024 and is expected to reach USD 52.6 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

This growth reflects rising demand for advanced imaging technologies like MRI machines, PET/CT scanners, and mammography systems amid increasing chronic disease prevalence and healthcare infrastructure expansion. Key drivers include technological innovations in AI-integrated diagnostics, an aging global population boosting early detection needs, and government investments in medical equipment upgrades, particularly in emerging markets.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/diagnostic-imaging-devices-market?ram

United States: Key Industry Developments
✅ December 2025: Royal Philips launched Verida, the world's first detector-based CT imaging solution with AI capabilities, unveiled at RSNA 2025 to enhance diagnostic precision and workflow efficiency.

✅ May 2025: NVIDIA and Philips collaborated on a foundational AI model for MRI, aimed at boosting diagnostic accuracy, accelerating scan times, and elevating image quality across clinical uses.

Europe: Key Industry Developments
✅ March 2025: Bunkerhill Health partnered with Cleerly to advance noninvasive cardiovascular imaging via AI-powered coronary CT angiography, improving diagnostic outcomes.

✅ January 2025: Sutter Health entered a seven-year strategic imaging partnership with GE HealthCare, covering PET/CT, SPECT/CT, MRI, CT, X-ray, and ultrasound systems.

Global: Key Industry Developments
✅ December 2025: Royal Philips announced Verida at RSNA 2025, a pioneering detector-based CT system integrating AI to streamline diagnostics and boost productivity worldwide.

✅ May 2025: NVIDIA and Philips jointly developed an AI foundation model for MRI scanners, targeting global improvements in speed, quality, and accuracy for diverse applications.

Key Merges and Acquisitions(2025):
✅ GE HealthCare and NVIDIA partner for imaging solutions: In December 2025, GE HealthCare partnered with NVIDIA to integrate NVIDIA technology into its new imaging solutions, including Photonova Spectra, SIGNA Sprint with Freelium, SIGNA Bolt, Vivid Pioneer, and Pristina Recon DL. This collaboration will support timely diagnoses and streamlined clinical workflows.

✅ Siemens Healthineers and NVIDIA partner on Optiq AI: In November 2025, Siemens Healthineers introduced its new AI-powered Optiq AI imaging chain at RSNA 2025, which uses artificial intelligence to deliver high-quality, low-dose images for precise image-guided procedures.

✅ GE HealthCare acquires Intelerad: GE HealthCare acquired medical imaging software provider Intelerad for approximately $2.3 billion in cash.

✅ Blackstone & TPG to acquire Hologic: Funds managed by Blackstone and TPG announced plans to acquire Hologic, privatizing the company.

Market Segmentation Analysis:
-By Product Type: X-ray Leads with High Volume Demand
X-ray systems hold the largest share at 35%, favored for their affordability, speed, and widespread use in routine diagnostics like bone fractures and chest imaging.​
Ultrasound captures 25%, driven by real-time, non-invasive imaging in obstetrics and cardiology without radiation risks.​
CT scanners command 20%, excelling in detailed cross-sectional views for oncology and trauma, while MRI at 15% dominates soft tissue analysis, and nuclear imaging at 5% supports functional assessments.​

-By Imaging Type: Stationary Systems Dominate Infrastructure
Stationary imaging leads with 70% share, integral to hospital radiology departments for high-resolution, fixed installations like full-body CT and MRI scanners.​
Portable systems take 30%, growing via compact X-ray and ultrasound units for bedside, emergency, and remote diagnostics.​

-By Portability: Trolley/Cart-Based Prevails Over Handhelds
Trolley-based/portable systems account for 74%, offering robust mobility for hospital floors and clinics with advanced features like 3D ultrasound.​
Handheld/portable units hold 26%, surging in point-of-care settings due to affordability and ease in primary care.​

-By Application: Oncology Drives Diagnostic Volume
Oncology leads with 28% share, relying on CT, MRI, and PET for tumor detection and staging.​
Cardiology follows at 22% for vascular imaging, neurology at 18% for brain scans, OB/Gyn at 15%, orthopedics at 10%, and others at 7% covering general uses.​

-By End-User: Hospitals Command Majority Installations
Hospitals dominate with 75% market share, equipped for comprehensive imaging across all modalities due to high patient volumes.​
Diagnostic centers hold 15% for specialized outpatient services, and others like clinics take 10%, focusing on portable tech.​

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=diagnostic-imaging-devices-market?ram (Purchase 2 or more Reports and get 50% Discount)

Growth Drivers:
-Rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and diabetes, boosts demand for early detection and monitoring through imaging.​

-Technological advancements, including AI integration, hybrid modalities, 3D/4D imaging, and portable devices, enhance diagnostic accuracy and efficiency.​

-Growing geriatric population increases vulnerability to age-related conditions requiring frequent imaging diagnostics.​

-Expansion of healthcare infrastructure and government investments in emerging economies improve access to advanced imaging systems.​

-Heightened focus on early disease detection, preventive medicine, and minimally invasive diagnostics drives adoption across clinical applications.

Regional Insights:
-North America holds the largest market share in the diagnostic imaging devices market, accounting for approximately 40% of the global total as of recent estimates, driven by advanced healthcare infrastructure, robust reimbursement systems, and high adoption of AI-enabled imaging innovations. This region's dominance is further supported by a high number of product approvals and established players focusing on cutting-edge technologies like CT and MRI systems. Strong investments in research and development continue to solidify its leadership position through 2030.​

-Europe ranks second in market share, particularly Western Europe leading with significant portions due to integrated enterprise imaging solutions and compliance with stringent regulations like GDPR. The region benefits from mature healthcare systems in countries such as Germany, France, and the UK, emphasizing data protection and advanced diagnostics for chronic diseases. Steady growth is projected, though slightly tempered by budgetary constraints in Eastern Europe.​

-Asia Pacific follows as the third-largest region by share, rapidly expanding with a projected CAGR of around 7.5% from 2025 onward, fueled by healthcare infrastructure development in China, India, and Southeast Asia. Rising chronic disease prevalence, aging populations, and increasing access to advanced equipment like oncology-focused imaging are key drivers. China is expected to hold a substantial portion within this region, boosting overall demand.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/diagnostic-imaging-devices-market?ram

Key Players:
Siemens Healthineers AG | GE HealthCare | Koninklijke Philips N.V. | CANON MEDICAL SYSTEMS CORPORATION | FUJIFILM Holdings Corporation | Medtronic plc | Hologic, Inc. | Abbott Laboratories | Shenzhen Mindray Bio-Medical Electronics Co. Ltd | Carestream Health

Key Highlights (Top 5 Key Players) for Diagnostic Imaging Devices Market:
-GE HealthCare reported $5.1 billion in Q3 2025 revenues, up 6% year-over-year, with strong growth in its imaging segment driven by demand for advanced diagnostic equipment.​

-Siemens Healthineers AG leads the global diagnostic imaging market as the top player by share in 2024, focusing on innovations in MRI, CT, and ultrasound systems.​

-Koninklijke Philips N.V. holds a significant portion of the diagnostic imaging market alongside peers, emphasizing integrated imaging solutions for cardiology and oncology.​

-Canon Medical Systems Corporation ranks among the top five in diagnostic imaging market share for 2024, with strengths in CT and MRI technologies.​

-FUJIFILM Holdings Corporation maintains a leading position in the diagnostic imaging sector, driven by advancements in X-ray and ultrasound portfolios.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.